Evidence map›Paper›PMID 37033157›Full record

ArticlePhysical review research

Three-dimensional cancer cell migration directed by dual mechanochemical guidance.

Pedram Esfahani, Herbert Levine, Mrinmoy Mukherjee, Bo Sun

Open access · goldAbstract read
In one paragraph

Article in Physical review research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Pedram EsfahaniDepartment of Physics, Oregon State University, Corvallis, Oregon 97331, USA.ORCID 0000-0002-6888-3386
Herbert LevineCenter for Theoretical Biological Physics, Northeastern University, Boston, Massachusetts 02115, USA.ORCID 0000-0002-8819-9055
Mrinmoy MukherjeeCenter for Theoretical Biological Physics, Northeastern University, Boston, Massachusetts 02115, USA.ORCID 0000-0003-4927-2464
Bo SunDepartment of Physics, Oregon State University, Corvallis, Oregon 97331, USA.ORCID 0000-0001-7001-8781
Northeastern University · USOregon State University · US

Funding

Understanding the control mechanisms of 3D cell migration from new dimensionsR35GM138179 · NIGMS · OREGON STATE UNIVERSITY · PI SUN, BO · 2020 to 2024
$1.9M
NIGMS NIH HHS R35 GM138179
6 · The paper itself

Abstract

Directed cell migration guided by external cues plays a central role in many physiological and pathophysiological processes. The microenvironment of cells often simultaneously contains various cues and the motility response of cells to multiplexed guidance is poorly understood. Here we combine experiments and mathematical models to study the three-dimensional migration of breast cancer cells in the presence of both contact guidance and a chemoattractant gradient. We find that the chemotaxis of cells is complicated by the presence of contact guidance as the microstructure of extracellular matrix (ECM) vary spatially. In the presence of dual guidance, the impact of ECM alignment is determined externally by the coherence of ECM fibers and internally by cell mechanosensing Rho/Rock pathways. When contact guidance is parallel to the chemical gradient, coherent ECM fibers significantly increase the efficiency of chemotaxis. When contact guidance is perpendicular to the chemical gradient, cells exploit the ECM disorder to locate paths for chemotaxis. Our results underscore the importance of fully characterizing the cancer cell microenvironment in order to better understand invasion and metastasis.

Identifiers

PMID37033157
PMCPMC10081505
OpenAlexW4225865026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.